Global Premature Ejaculation Treatment Market Research Report 2023

Publisher Name :
Date: 10-Jan-2023
No. of pages: 93
Inquire Before Buying

Common treatment options for premature ejaculation include behavioral techniques, topical anesthetics, medications and counseling. Keep in mind that it might take time to find the treatment or combination of treatments that will work for you. Behavioral treatment plus drug therapy might be the most effective course.

Highlights

The global Premature Ejaculation Treatment market was valued at US$ 3149.9 million in 2022 and is anticipated to reach US$ 5341.1 million by 2029, witnessing a CAGR of 9.2% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Premature Ejaculation Treatment key players include Pfizer, Novartis, Eli Lilly, Johnson & Johnson, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Premature Ejaculation Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Premature Ejaculation Treatment.

The Premature Ejaculation Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Premature Ejaculation Treatment market comprehensively. Regional market sizes, concerning products by type, by distribution channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Premature Ejaculation Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by distribution channel, and by regions.

By Company

- Pfizer

- Novartis

- Eli Lilly

- Johnson & Johnson

- GlaxoSmithKline

- Bayer

- Menarini

- Teva

- Sunrise Pharma

- Regent Pacific

- Torrent Pharma

- Vivus

Segment by Type

- Antidepressants(SSRIs)

- Phosphodiesterase-5 Inhibitors

- Topical Anesthetics

- Analgesics

- Other Treatment

Segment by Distribution Channel

- Hospital

- Retail Pharmacy

- Online Pharmacy

- Other

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, distribution channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Premature Ejaculation Treatment companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by distribution channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Premature Ejaculation Treatment Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Premature Ejaculation Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antidepressants(SSRIs)
1.2.3 Phosphodiesterase-5 Inhibitors
1.2.4 Topical Anesthetics
1.2.5 Analgesics
1.2.6 Other Treatment
1.3 Market by Distribution Channel
1.3.1 Global Premature Ejaculation Treatment Market Growth by Distribution Channel: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Premature Ejaculation Treatment Market Perspective (2018-2029)
2.2 Premature Ejaculation Treatment Growth Trends by Region
2.2.1 Global Premature Ejaculation Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Premature Ejaculation Treatment Historic Market Size by Region (2018-2023)
2.2.3 Premature Ejaculation Treatment Forecasted Market Size by Region (2024-2029)
2.3 Premature Ejaculation Treatment Market Dynamics
2.3.1 Premature Ejaculation Treatment Industry Trends
2.3.2 Premature Ejaculation Treatment Market Drivers
2.3.3 Premature Ejaculation Treatment Market Challenges
2.3.4 Premature Ejaculation Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Premature Ejaculation Treatment Players by Revenue
3.1.1 Global Top Premature Ejaculation Treatment Players by Revenue (2018-2023)
3.1.2 Global Premature Ejaculation Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Premature Ejaculation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Premature Ejaculation Treatment Revenue
3.4 Global Premature Ejaculation Treatment Market Concentration Ratio
3.4.1 Global Premature Ejaculation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Premature Ejaculation Treatment Revenue in 2022
3.5 Premature Ejaculation Treatment Key Players Head office and Area Served
3.6 Key Players Premature Ejaculation Treatment Product Solution and Service
3.7 Date of Enter into Premature Ejaculation Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Premature Ejaculation Treatment Breakdown Data by Type
4.1 Global Premature Ejaculation Treatment Historic Market Size by Type (2018-2023)
4.2 Global Premature Ejaculation Treatment Forecasted Market Size by Type (2024-2029)
5 Premature Ejaculation Treatment Breakdown Data by Distribution Channel
5.1 Global Premature Ejaculation Treatment Historic Market Size by Distribution Channel (2018-2023)
5.2 Global Premature Ejaculation Treatment Forecasted Market Size by Distribution Channel (2024-2029)
6 North America
6.1 North America Premature Ejaculation Treatment Market Size (2018-2029)
6.2 North America Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Premature Ejaculation Treatment Market Size by Country (2018-2023)
6.4 North America Premature Ejaculation Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Premature Ejaculation Treatment Market Size (2018-2029)
7.2 Europe Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Premature Ejaculation Treatment Market Size by Country (2018-2023)
7.4 Europe Premature Ejaculation Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Premature Ejaculation Treatment Market Size (2018-2029)
8.2 Asia-Pacific Premature Ejaculation Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Premature Ejaculation Treatment Market Size (2018-2029)
9.2 Latin America Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Premature Ejaculation Treatment Market Size by Country (2018-2023)
9.4 Latin America Premature Ejaculation Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Premature Ejaculation Treatment Market Size (2018-2029)
10.2 Middle East & Africa Premature Ejaculation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Premature Ejaculation Treatment Introduction
11.1.4 Pfizer Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Premature Ejaculation Treatment Introduction
11.2.4 Novartis Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Premature Ejaculation Treatment Introduction
11.3.4 Eli Lilly Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.3.5 Eli Lilly Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Premature Ejaculation Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Premature Ejaculation Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Premature Ejaculation Treatment Introduction
11.6.4 Bayer Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.6.5 Bayer Recent Development
11.7 Menarini
11.7.1 Menarini Company Detail
11.7.2 Menarini Business Overview
11.7.3 Menarini Premature Ejaculation Treatment Introduction
11.7.4 Menarini Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.7.5 Menarini Recent Development
11.8 Teva
11.8.1 Teva Company Detail
11.8.2 Teva Business Overview
11.8.3 Teva Premature Ejaculation Treatment Introduction
11.8.4 Teva Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.8.5 Teva Recent Development
11.9 Sunrise Pharma
11.9.1 Sunrise Pharma Company Detail
11.9.2 Sunrise Pharma Business Overview
11.9.3 Sunrise Pharma Premature Ejaculation Treatment Introduction
11.9.4 Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.9.5 Sunrise Pharma Recent Development
11.10 Regent Pacific
11.10.1 Regent Pacific Company Detail
11.10.2 Regent Pacific Business Overview
11.10.3 Regent Pacific Premature Ejaculation Treatment Introduction
11.10.4 Regent Pacific Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.10.5 Regent Pacific Recent Development
11.11 Torrent Pharma
11.11.1 Torrent Pharma Company Detail
11.11.2 Torrent Pharma Business Overview
11.11.3 Torrent Pharma Premature Ejaculation Treatment Introduction
11.11.4 Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.11.5 Torrent Pharma Recent Development
11.12 Vivus
11.12.1 Vivus Company Detail
11.12.2 Vivus Business Overview
11.12.3 Vivus Premature Ejaculation Treatment Introduction
11.12.4 Vivus Revenue in Premature Ejaculation Treatment Business (2018-2023)
11.12.5 Vivus Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Premature Ejaculation Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Antidepressants(SSRIs)
Table 3. Key Players of Phosphodiesterase-5 Inhibitors
Table 4. Key Players of Topical Anesthetics
Table 5. Key Players of Analgesics
Table 6. Key Players of Other Treatment
Table 7. Global Premature Ejaculation Treatment Market Size Growth by Distribution Channel (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Premature Ejaculation Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Premature Ejaculation Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Premature Ejaculation Treatment Market Share by Region (2018-2023)
Table 11. Global Premature Ejaculation Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Premature Ejaculation Treatment Market Share by Region (2024-2029)
Table 13. Premature Ejaculation Treatment Market Trends
Table 14. Premature Ejaculation Treatment Market Drivers
Table 15. Premature Ejaculation Treatment Market Challenges
Table 16. Premature Ejaculation Treatment Market Restraints
Table 17. Global Premature Ejaculation Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Premature Ejaculation Treatment Market Share by Players (2018-2023)
Table 19. Global Top Premature Ejaculation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premature Ejaculation Treatment as of 2022)
Table 20. Ranking of Global Top Premature Ejaculation Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Premature Ejaculation Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Premature Ejaculation Treatment Product Solution and Service
Table 24. Date of Enter into Premature Ejaculation Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Premature Ejaculation Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Premature Ejaculation Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Premature Ejaculation Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Premature Ejaculation Treatment Revenue Market Share by Type (2024-2029)
Table 30. Global Premature Ejaculation Treatment Market Size by Distribution Channel (2018-2023) & (US$ Million)
Table 31. Global Premature Ejaculation Treatment Revenue Market Share by Distribution Channel (2018-2023)
Table 32. Global Premature Ejaculation Treatment Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)
Table 33. Global Premature Ejaculation Treatment Revenue Market Share by Distribution Channel (2024-2029)
Table 34. North America Premature Ejaculation Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Premature Ejaculation Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Premature Ejaculation Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Premature Ejaculation Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Premature Ejaculation Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 49. Pfizer Company Detail
Table 50. Pfizer Business Overview
Table 51. Pfizer Premature Ejaculation Treatment Product
Table 52. Pfizer Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 53. Pfizer Recent Development
Table 54. Novartis Company Detail
Table 55. Novartis Business Overview
Table 56. Novartis Premature Ejaculation Treatment Product
Table 57. Novartis Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. Eli Lilly Company Detail
Table 60. Eli Lilly Business Overview
Table 61. Eli Lilly Premature Ejaculation Treatment Product
Table 62. Eli Lilly Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 63. Eli Lilly Recent Development
Table 64. Johnson & Johnson Company Detail
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Premature Ejaculation Treatment Product
Table 67. Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 68. Johnson & Johnson Recent Development
Table 69. GlaxoSmithKline Company Detail
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Premature Ejaculation Treatment Product
Table 72. GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 73. GlaxoSmithKline Recent Development
Table 74. Bayer Company Detail
Table 75. Bayer Business Overview
Table 76. Bayer Premature Ejaculation Treatment Product
Table 77. Bayer Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 78. Bayer Recent Development
Table 79. Menarini Company Detail
Table 80. Menarini Business Overview
Table 81. Menarini Premature Ejaculation Treatment Product
Table 82. Menarini Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 83. Menarini Recent Development
Table 84. Teva Company Detail
Table 85. Teva Business Overview
Table 86. Teva Premature Ejaculation Treatment Product
Table 87. Teva Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 88. Teva Recent Development
Table 89. Sunrise Pharma Company Detail
Table 90. Sunrise Pharma Business Overview
Table 91. Sunrise Pharma Premature Ejaculation Treatment Product
Table 92. Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 93. Sunrise Pharma Recent Development
Table 94. Regent Pacific Company Detail
Table 95. Regent Pacific Business Overview
Table 96. Regent Pacific Premature Ejaculation Treatment Product
Table 97. Regent Pacific Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 98. Regent Pacific Recent Development
Table 99. Torrent Pharma Company Detail
Table 100. Torrent Pharma Business Overview
Table 101. Torrent Pharma Premature Ejaculation Treatment Product
Table 102. Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 103. Torrent Pharma Recent Development
Table 104. Vivus Company Detail
Table 105. Vivus Business Overview
Table 106. Vivus Premature Ejaculation Treatment Product
Table 107. Vivus Revenue in Premature Ejaculation Treatment Business (2018-2023) & (US$ Million)
Table 108. Vivus Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Premature Ejaculation Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Premature Ejaculation Treatment Market Share by Type: 2022 VS 2029
Figure 3. Antidepressants(SSRIs) Features
Figure 4. Phosphodiesterase-5 Inhibitors Features
Figure 5. Topical Anesthetics Features
Figure 6. Analgesics Features
Figure 7. Other Treatment Features
Figure 8. Global Premature Ejaculation Treatment Market Size Comparison by Distribution Channel (2023-2029) & (US$ Million)
Figure 9. Global Premature Ejaculation Treatment Market Share by Distribution Channel: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Online Pharmacy Case Studies
Figure 13. Other Case Studies
Figure 14. Premature Ejaculation Treatment Report Years Considered
Figure 15. Global Premature Ejaculation Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Premature Ejaculation Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Premature Ejaculation Treatment Market Share by Region: 2022 VS 2029
Figure 18. Global Premature Ejaculation Treatment Market Share by Players in 2022
Figure 19. Global Top Premature Ejaculation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premature Ejaculation Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Premature Ejaculation Treatment Revenue in 2022
Figure 21. North America Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Premature Ejaculation Treatment Market Share by Country (2018-2029)
Figure 23. United States Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Premature Ejaculation Treatment Market Share by Country (2018-2029)
Figure 27. Germany Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Premature Ejaculation Treatment Market Share by Region (2018-2029)
Figure 35. China Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Premature Ejaculation Treatment Market Share by Country (2018-2029)
Figure 43. Mexico Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Premature Ejaculation Treatment Market Share by Country (2018-2029)
Figure 47. Turkey Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Premature Ejaculation Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Pfizer Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 51. Eli Lilly Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 52. Johnson & Johnson Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 54. Bayer Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 55. Menarini Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 56. Teva Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 57. Sunrise Pharma Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 58. Regent Pacific Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 59. Torrent Pharma Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 60. Vivus Revenue Growth Rate in Premature Ejaculation Treatment Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
  • Global Testosterone Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113
    According to our LPI (LP Information) latest study, the global Testosterone Replacement Therapy market size was valued at US$ 1493.3 million in 2023. With growing demand in downstream market, the Testosterone Replacement Therapy is forecast to a readjusted size of US$ 1101.6 million by 2030 with a CAGR of -4.3% during review period. The research report highlights the growth potential of the global Testosterone Replacement Therapy market. Testosterone Replacement Therapy are expected to s......
  • Global Finasteride Tablets Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The Finasteride Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Finasteride Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Global Erectile Dysfunction Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Erectile Dysfunction Drugs market size was valued at US$ 4749.4 million in 2023. With growing demand in downstream market, the Erectile Dysfunction Drugs is forecast to a readjusted size of US$ 7247.8 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Erectile Dysfunction Drugs market. Erectile Dysfunction Drugs are expected to show stable growth in the ......
  • Global Methyltestosterone Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 75
    The Methyltestosterone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methyltestosterone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles......
  • Global Tamsulosin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Tamsulosin market: According to our latest research, the global Tamsulosin market looks promising in the next 5 years. As of 2022, the global Tamsulosin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Tamsulosin market, with a systematical de......
  • Global Erectile Dysfunction Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Erectile Dysfunction Drug market: According to our latest research, the global Erectile Dysfunction Drug market looks promising in the next 5 years. As of 2022, the global Erectile Dysfunction Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Finasteride Tablets Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 98
    Market Overview of Global Finasteride Tablets market: According to our latest research, the global Finasteride Tablets market looks promising in the next 5 years. As of 2022, the global Finasteride Tablets market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Finasteride Ta......
  • Finasteride Tablets - Global Market Insights and Sales Trends 2024
    Published: 19-Dec-2023        Price: US 3350 Onwards        Pages: 106
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Finasteride Tablets, with both quantit......
  • Global Duchenne Muscular Dystrophy Drugs Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 134
    Report Overview: The Global Duchenne Muscular Dystrophy Drugs Market Size was estimated at USD 8086.70 million in 2022 and is projected to reach USD 62734.28 million by 2029, exhibiting a CAGR of 34.00% during the forecast period. This report provides a deep insight into the global Duchenne Muscular Dystrophy Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs